A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of… read more.
For the first time, researchers have successfully injected cultured red blood cells (cRBCs) created from human hematopoietic stem cells (HSCs) into a human donor, according to study results… read more.
Pictured: Dr. Yael P. Mosse is a pediatric oncologist at The Children’s Hospital of Philadelphia. Children’s Hospital of Philadelphia researcher leads trial of ALK inhibitor in neuroblastoma, lymphoma. … read more.
A key goal of MIRT is to train and mentor the clinician scientists of the future. An Interview with Dr. Peter O’Gorman, Consultant Haematologist, at the Mater University… read more.
A key goal of MIRT is to train and mentor the clinician scientists of the future. An Interview with Dr. Peter O’Gorman, Consultant Haematologist, at the Mater University… read more.
An investigational oral drug delayed disease relapse for nearly a year in some patients with advanced non-small cell lung cancer (NSCLC).
Residents of Lower Manhattan who suffered home damage following the September 11 terrorist attacks are more likely to report respiratory symptoms and diseases than area residents whose homes… read more.
Worldwide increases in the incidences of asthma, allergies, infectious and cardiovascular diseases will result from a variety of impacts of global climate change,
Patients with advanced chronic obstructive pulmonary disease (COPD) and shortness of breath found that opioids provided relief and improved their quality of life,
Gordon D. Rubenfeld, M.D., of the Sunnybrook Health Sciences Center, Toronto, Canada, and colleagues with the ARDS (acute respiratory distress syndrome) Definition Task Force, developed a new definition… read more.
New drug helps preterm infants breathe. “I am excited that our scientific findings will help save lives,” said Charles Cochrane, MD, professor emeritus. “Many years of work in… read more.
Limited access to clean sources of energy, known as energy poverty, makes nearly half the world’s population reliant on burning wood, animal waste, coal or charcoal to cook.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
